Today: 20 May 2026
C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers
30 January 2026
1 min read

C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers

NEW YORK, January 30, 2026, 08:55 EST — Premarket

C3.ai Inc shares slipped roughly 2% to $12.01 in premarket on Friday, after dropping 6.6% to close at $12.26 the previous day.

Shares moved after a report from The Information that C3.ai is negotiating a merger with Automation Anywhere. The deal would involve the private automation software firm acquiring C3.ai and then going public through the merger. Reuters couldn’t independently confirm the story, and neither company responded to requests for comment. Automation Anywhere was valued at $6.8 billion by private investors back in 2019. C3.ai, which counts the U.S. Air Force among its clients, has been exploring strategic alternatives since founder Thomas Siebel stepped down as CEO. Its stock has fallen over 59% in the past year.

The timing couldn’t be worse. Software stocks dropped on Thursday amid fears that fast-moving AI innovations might upend the software-as-a-service model that drives much of the industry. “The market is … pricing a worst-case scenario that software is dead because AI is disrupting the space,” said Adam Turnquist, chief technical strategist at LPL Financial. Reuters

C3.ai’s stock dropped 6.63% on Thursday, with roughly 10.3 million shares changing hands, well above its 50-day average volume of around 6 million, according to MarketWatch. The share price now sits roughly two-thirds below its 52-week peak of $35.98.

A reverse merger offers a shortcut to public markets: a private company acquires a listed firm and takes over its stock exchange listing, bypassing the usual initial public offering process.

C3.ai investors are left wondering about the price and conditions. The stock’s wild moves since the news hit reflect traders scrambling to gauge if the talks will actually lead somewhere—and how quickly.

Merger talks can also fall apart. If they can’t settle on valuation or deal structure, or if negotiations stall, shares might slip back to the lows from earlier this week.

Investors are waiting for a clearer signal from one of the companies. A formal announcement or a filing indicating a structured process could trigger the next step.

C3.ai’s quarterly earnings report is on deck, with Nasdaq data pointing to a release around Feb. 25.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Bitmine (BMNR) stock slides premarket after president exit filing as crypto rout deepens
Previous Story

Bitmine (BMNR) stock slides premarket after president exit filing as crypto rout deepens

Micron stock price today: MU rises as Samsung and Apple highlight memory-chip squeeze
Next Story

Micron stock price today: MU rises as Samsung and Apple highlight memory-chip squeeze

Go toTop